EUVIMEDEUVIMED entdecken
Fallbericht

Four cancer cases with pathological germline variant RAD51D c.270_271dup

Eiko Ishihara, Hiroyuki Matsubayashi iD, Seiichiro Nishimura, Mitsuhiro Isaka, Hayato Konno, Seiya Goto, Ken Yamaguchi, Kenichi Urakami

Journal of Obstetrics and Gynaecology Research · 2024

DOI: 10.1111/jog.16045 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Eiko Ishihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Germ-Line Mutation. Die Arbeit nennt 15 Literaturangaben. Gefördert von: This research was supported by AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological germline variants (PGVs) of RAD51D increase the risk of breast and ovarian cancer. In East Asia, c.270_271dup is the most frequently detected PGV of RAD51D ; however, only a few cases have been reported in Japan. We report four cancer cases with a germline RAD51D c.270_271dup PGV. Three of them (lung cancer: 2, oral cancer: 1) were incidentally identified by whole genome sequencing in patients negative for the associated cancer histories, homologous recombination (HR) deficiency, or a second hit of RAD51D in the cancer DNA. For genetic counseling, we provided information on surveillance and cascade testing based on Western guidelines. The PGVs of moderate‐risk HR‐related genes are difficult to detect based on phenotype, especially in male‐predominant pedigrees. The current spread of cancer genomic analysis will increase opportunities for incidental variant identification. The establishment of Japanese guidelines is expected to aid in the management of PGV carriers of moderate‐risk genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsGerm-Line MutationAgedFemaleHumansMaleMiddle AgedGenetic Predisposition to DiseaseJapanLung NeoplasmsAged, 80 and over

Stichwörter der Autor:innen

RAD51D 270_271dupcancer riskgermlinemoderate‐risk cancer gene

Substanzen

DNA-Binding ProteinsRAD51D protein, human

Autor:innen und Institutionen

  • Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Breast Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Respiratory Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Division of Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.

ORCID-Profile: Hiroyuki Matsubayashi

Förderung

  • This research was supported by AMED

Zitieren

APA

Ishihara, E., Matsubayashi, H., Nishimura, S., Isaka, M., Konno, H., Goto, S., Yamaguchi, K., & Urakami, K. (2024). Four cancer cases with pathological germline variant RAD51D c.270_271dup. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16045

Vancouver

Ishihara E, Matsubayashi H, Nishimura S, Isaka M, Konno H, Goto S, et al. Four cancer cases with pathological germline variant RAD51D c.270_271dup. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16045

BibTeX
@article{Ishihara2024,
  author = {Ishihara, Eiko and Matsubayashi, Hiroyuki and Nishimura, Seiichiro and Isaka, Mitsuhiro and Konno, Hayato and Goto, Seiya and Yamaguchi, Ken and Urakami, Kenichi},
  title = {Four cancer cases with pathological germline variant RAD51D c.270_271dup},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  doi = {10.1111/jog.16045}
}
Kostenlos starten →